Simulated microgravity-driven mechanical unloading rescues PIEZO1-overexpression-induced growth plate ossification and retards adolescent idiopathic scoliosis Authors: Fei Chen, Shuqing Chen, Xingzhi Jing, Fushuai Peng, Yukun Du, Jianyi Li, Yuanyuan Fan, Zichen Cui, Guanghui Gu, Han Zhang, Jun Dong, Tao Li, Yongming Xi Published: 2026 ABSTRACT AbstractAdolescent Idiopathic Scoliosis (AIS) progresses via excessive concave-endplate compressive stress and PIEZO1 overexpression-induced vertebral growth plate chondrocyte degeneration. Though microgravity-mediated mechanical unloading is traditionally linked to musculoskeletal harm, we explored its therapeutic potential for AIS. We integrated clinical observations, in vivo models, and in vitro experiments: Clinical anti-gravity skull traction (mechanical unloading) reduced a severe AIS patient’s Cobb angle. In a scoliosis mouse model, 10 h/day traction suspension delayed deformity. In vitro, 100 kPa pressure overload upregulated PIEZO1 in chondrocytes, while simulated microgravity reversed this, inhibiting ossification and matrix degeneration. Mouse tail compression elevated PIEZO1 and accelerated ossification, which tail suspension reversed. PIEZO1 agonist Yoda1 promoted chondrocyte osteogenic differentiation, confirming PIEZO1’s pathological role. This study shows simulated microgravity-mediated mechanical unloading alleviates AIS by inhibiting PIEZO1, repurposing microgravity from a “pathological factor” to a non-invasive AIS therapy, bridging aerospace medicine and orthopedics.Subject terms: Cell biology, Diseases, Engineering, Medical research Introduction The unique bipedal locomotion of humans causes biomechanical factors, especially compressive stress, to be deeply involved in the regulation of spinal physiological functions and pathological processes. When the spinal endplate cartilage is exposed to excessive pressure loads, it triggers catabolic reactions and leads to massive cell death. Adolescent Idiopathic Scoliosis (AIS), a disease characterized by developmental disorders of the vertebral growth plate, is a common type of spinal deformity in adolescents. It often progresses rapidly during the child’s growth and development period, resulting in severe deformities. Studies have confirmed that the concave endplates of AIS patients continuously bear increased compressive stress1,2. Our previous studies further revealed that the stress-induced overexpression of PIEZO1 is closely associated with the progression of scoliosis3,4. PIEZO1 is a newly discovered mechanosensitive ion channel that has been extensively studied in recent years, and its activation can induce cell death5. Latest research indicates that as a Ca²⁺-permeable ion channel, PIEZO1 plays a core role in mechanical stimulus-mediated calcium influx, thereby regulating the physiological states of various cells, including chondrocytes6–9. Our previous research showed that PIEZO1 exhibits differential expression between the convex and concave sides of the vertebral growth plate in AIS. Moreover, its overexpression promotes excessive apoptosis and ferroptosis of growth plate chondrocytes, exacerbating AIS progression. In contrast, inhibiting PIEZO1 can effectively delay the progression of deformity in scoliosis mice—local delivery of the PIEZO1 inhibitor GsMTx4 to the vertebral growth plate using biomaterials can avoid side effects caused by systemic inhibition, providing a potential direction for AIS treatment3,4. However, this approach still belongs to invasive treatment, so we have continued to explore non-invasive therapeutic strategies thereafter. With the development of aerospace medicine, the microgravity environment has long been regarded as a special environment harmful to the human body. Especially in the field of orthopedics, there is an increasing number of studies on the effects of microgravity on bone-related diseases. Recent studies have found that mechanical unloading under microgravity can downregulate the expression of PIEZO1 in bone tissue and induce cell resistance to apoptosis10,11. Combining the conclusions of our previous studies on the role of PIEZO1 in AIS and the mechanical principles of clinical skull traction therapy12,13, the mechanical unloading phenomenon mediated by microgravity may be transformed into a therapeutic method to delay the progression of scoliosis. In this study, we first analyzed the correlation between the mechanical principles of skull traction and the therapeutic effect of AIS through clinical observations. Subsequently, a scoliosis mouse model was established, and suspension-based mechanical unloading was used to simulate the in vivo biological effects of microgravity. It was found that this treatment could relatively delay the progression of scoliosis. In in vitro experiments, primary vertebral growth plate chondrocytes were isolated and cultured. A cell compression system was used to simulate the mechanical overload during scoliosis progression, and a random positioning machine was applied to the compressed cells to simulate microgravity, aiming to explore the regulatory role of mechanical unloading. Meanwhile, mouse tail compression/suspension was used to simulate mechanical overload and unloading, respectively. The results showed that mechanical unloading mediated by simulated microgravity could reduce the overexpression of PIEZO1 induced by pressure overload, thereby inhibiting the degeneration of growth plate chondrocytes. This study indicates that mechanical unloading achieved by simulating a microgravity environment can counteract the degeneration of growth plate chondrocytes caused by PIEZO1 overexpression. This provides a potential non-invasive therapeutic approach for delaying the progression of scoliosis and also represents a valuable attempt in medical research to “transform the counteractive effect of microgravity into a utilizable effect”. Results Mechanical unloading improves scoliosis severity and delays its progression in the early disease stage The essence of the anti-gravity skull traction protocol is a therapeutic approach that achieves spinal mechanical unloading by counteracting the patient’s own gravity. From a simplified mechanical principle analysis: under normal physiological conditions, the force (F) borne by the human spine is approximately equal to the body’s own gravity (G1); however, after applying a traction force (G2) to the spine via skull traction in the direction opposite to the body’s gravity, the actual force borne by the spine becomes F = G1 − G2, thereby achieving substantial mechanical unloading in an indirect manner (Fig. 1A). Mechanical unloading improves scoliosis severity and delays its progression in the early disease stage. A Simplified Force Analysis of the Spine in Physiological and Traction States. B X-ray Demonstration of the Effect of Skull Traction for 3 Weeks on Scoliosis. C. Schematic Diagram of Mechanical Unloading Caused by Suspension-Simulated Microgravity in Scoliotic Mice. D Comparison of scoliosis progression between 4‑week suspension traction and no traction in scoliotic mice. In each group, the left image represents T = 0 (baseline) and the right image represents T = 4 weeks. E Comparison of 4-week suspension traction and non-traction on the progression rate of scoliosis in mice with scoliosis. All data are presented as the mean ± SD, with n ≥ 3. Significance was indicated as follows: ***P < 0.001. Herein, we present the treatment outcome of one patient with severe scoliosis from our clinical practice, aiming to illustrate the potential efficacy of anti-gravity traction in reducing the severity of spinal scoliosis. The patient weighed 62 kg. The initial traction weight was 3 kg, which was increased by 2 kg daily according to the patient’s tolerance, reaching a final traction weight of 30 kg. Traction was applied for at least 10 h per day for a total of 3 weeks. Before anti-gravity skull traction, whole-spine X-ray was performed, and the Cobb angle was measured to be 79.52°. After 3 weeks of anti-gravity skull traction, follow-up whole-spine X-ray was conducted, and the Cobb angle was measured to be 37.78°. These results indicate that anti-gravity skull traction acutely reduced the scoliotic angle (Fig. 1B). It should be noted that this method is currently mainly used as an adjuvant pre-surgical intervention for severe scoliosis, with the core objective of reducing the difficulty of subsequent surgery. Notably, continuous traction for 10 h daily is not feasible for long-term clinical application, which supports the need to develop optimized microgravity simulation strategies. To further investigate whether initiating anti-gravity traction in the early stage after scoliosis onset can delay deformity progression, we established a bipedal standing mouse model. After scoliosis was confirmed (Cobbå 10°) in the mice via X-ray examination, the mice were divided into two groups: one group underwent 10 h of daily traction suspension to achieve mechanical unloading, while the other group was reared normally as the control group (Fig. 1C). After 1 month of observation and feeding, X-ray results showed that the progression of scoliosis in the traction-suspension group was significantly delayed. The scoliosis progression rate was calculated based on changes in the Cobb angle, and it was found that the progression rate in the traction-suspension group was significantly lower than that in the control group, being approximately 50% lower (Fig. 1D, E). In summary, the above results indicate that anti-gravity traction not only serves as an adjuvant pre-surgical protocol for severe scoliosis—reducing the Cobb angle through mechanical unloading to lower surgical difficulty—but may delay disease progression in the early stage of scoliosis via mechanical unloading, as supported by our mouse model data. Changes in the mechanical environment regulate PIEZO1 expression in vertebral growth plate cartilage In previous studies, we have confirmed that PIEZO1 expression in growth plate chondrocytes is upregulated with increasing pressure intensity or prolonged pressure duration3,4. In the present study, we adopted the same experimental protocol and applied 100 kPa mechanical loading to growth plate chondrocytes. Western blot analysis showed that PIEZO1 expression was gradually upregulated in a time-dependent manner. Quantitative results further verified that PIEZO1 levels exhibited a significant increasing trend across the intervention groups with prolonged intervention time (P < 0.01) (Fig. 2A, B). The Random Positioning Machine (RPM) is widely used in studies related to simulating the space microgravity environment14–16. This study further explored changes in PIEZO1 expression in growth plate chondrocytes under RPM culture conditions; Western blot results showed that PIEZO1 expression was downregulated with the prolongation of RPM exposure time. Quantitative analysis further confirmed that PIEZO1 levels exhibited a significant decreasing trend among all groups after 3 h of RPM culture (P < 0.01). (Fig. 2C, D). Meanwhile, IHC staining performed in our mouse model further verified the regulatory effect of mechanical loading on PIEZO1 expression in vivo. In the control mice, PIEZO1 immunoreactivity in the caudal vertebral growth plate cartilage and endplates was relatively mild and uniformly distributed. By contrast, in mice subjected to tail compression, PIEZO1 expression was significantly upregulated in the growth plate cartilage of the caudal vertebrae, manifested as notably enhanced, darker brown positive staining in the endplate region, with a wider distribution of immunoreactive signals. Conversely, in the tail suspension group, PIEZO1 expression in the caudal vertebral growth plate cartilage was distinctly downregulated, characterized by markedly weakened, lighter brown staining and a substantial reduction in positive immunoreactive areas within the endplates (Fig. 2E). Quantitative IHC results also confirmed this conclusion, demonstrating that tail suspension substantially reduced the expression of PIEZO1 (Fig. 2F). The change in the mechanical environment induces expression changes of PIEZO1 in the vertebral growth plate cartilage. A, B Western blot bands and quantitative analysis of PIEZO1 in growth plate chondrocytes after 100 kPa mechanical loading at different time gradients. GAPDH was used as a loading control for Western blot analysis. C, D Western blot bands and quantitative analysis of PIEZO1 in growth plate chondrocytes after mechanical unloading (simulated microgravity via RPM) at different time gradients. GAPDH was used as a loading control for Western blot analysis. E Schematic diagram of caudal vertebra compression (via tail compression, TC) and caudal vertebra mechanical unloading (via tail suspension, TS) in mice, along with the immunohistochemical staining results of PIEZO1. F PIEZO1 immunohistochemical quantification analysis. All data are presented as the mean ± SD, with n ≥ 3. Significance was indicated as follows: ns (no significance), **P < 0.01, ***P < 0.001. Collectively, these results demonstrate that changes in the mechanical environment can significantly regulate PIEZO1 expression in vertebral growth plate cartilage. PIEZO1 overexpression promotes ossification and degeneration of vertebral growth plate chondrocytes To clarify this mechanism of action, we inoculated vertebral growth plate chondrocytes into osteogenic induction medium containing the PIEZO1 agonist Yoda1 at different concentrations. The degree of cellular ossification was evaluated via alkaline phosphatase (ALP) staining and alizarin red S (ARS) staining, while the degree of cartilage degeneration was assessed via alcian blue (ABS) staining. Results showed that with increasing Yoda1 concentration, the intensity of ALP staining and ARS staining increased, whereas the intensity of ABS staining decreased markedly. This suggests that PIEZO1 activation can simultaneously promote chondrocyte ossification and accelerate cartilage matrix degeneration (Fig. 3A). Western blot analysis further confirmed that Yoda1 treatment not only significantly upregulated PIEZO1 protein expression but also enhanced the protein expression of osteogenesis-related markers (COL1A2 and RUNX2), while significantly downregulating the protein expression of the cartilage-specific marker COL2A1. This verifies the regulatory role of PIEZO1 in the “transition from chondrocyte phenotype to osteoblast phenotype” at the molecular level (Fig. 3B, C). This finding at the cellular level was further validated in animal experiments: Safranin O/Fast Green staining demonstrated that no obvious ossification centers were observed in the vertebral endplates of control mice. In contrast, prominent ossification centers were clearly visible in the endplates of Yoda1-treated mice. These ossification centers appeared as well-demarcated, densely green-stained nodular structures with enlarged size, standing out distinctly against the surrounding red-stained cartilaginous matrix, indicating that activation of PIEZO1 by Yoda1 markedly promotes endplate ossification. (Fig. 3D). The cartilage endplates were scored according to the cartilage endplate scoring system in the intervertebral disc degeneration score17, and it was found that the endplate cartilage exhibited a higher degeneration score after Yoda1 treatment (Fig. 3E). PIEZO1 overexpression promotes ossification and degeneration of vertebral growth plate chondrocytes. A Vertebral growth plate chondrocytes were cultured in osteogenic induction medium containing different concentrations of the PIEZO1 agonist Yoda1. ALP and ARS were used to verify the osteogenesis degree, while ABS was used to verify the cartilage degeneration degree. B, C After culturing vertebral growth plate chondrocytes in osteogenic induction medium with different concentrations of the PIEZO1 agonist Yoda1, a fluorescent Western blot was performed to detect the bands of PIEZO1, osteogenic markers (COL1A2, RUNX2), and cartilage matrix markers, followed by quantitative analysis. GAPDH was used as a loading control for Western blot analysis. D Safranin O-fast green staining results of mice intraperitoneally injected with the PIEZO1 agonist Yoda1 and control mice. E End plate cartilage degeneration score based on intervertebral disc degeneration score. All data are presented as the mean ± SD, with n ≥ 3. Significance was indicated as follows: **P < 0.01, ***P < 0.001. These results clearly confirm that increased PIEZO1 expression can effectively promote the ossification and degeneration of vertebral growth plate chondrocytes, which is consistent with the findings of our previous study3. Microgravity‑induced mechanical unloading attenuates vertebral growth plate injury via inhibiting PIEZO1 In our previous study, we successfully simulated the progression of scoliosis via in vitro mechanical loading3. In the present study, we adopted the same protocol: vertebral growth plate chondrocytes were treated with 100 kPa pressure for 6 h to simulate the pressure overload state during scoliosis onset; subsequently, the pressure-treated chondrocytes were cultured under mechanical unloading conditions in a microgravity environment simulated by the Random Positioning Machine (RPM) (to simulate pressure unloading on the concave side of scoliosis), and detection and analysis were performed after 6 h of unloading culture (Fig. 4A). For comparison, additional control experiments were conducted as follows: 100 kPa compressive stress treatment for 6 h, treatment with the PIEZO1 inhibitor GsMTx4 alone for 6 h, and combined treatment with GsMTx4 and simulated microgravity mechanical unloading using RPM for 6 h. Western blot analysis showed that simulated microgravity mechanical unloading exerted an effect similar to that of GsMTx4, significantly downregulating PIEZO1 protein expression, and the combined treatment produced an even more pronounced effect. In accordance with the downregulation of PIEZO1, the expression of ossification-related proteins COL1A2 and RUNX2 was also inhibited (Fig. 4B, C). Immunofluorescence results were consistent with and confirmed the Western blot findings, suggesting that mechanical unloading effectively suppressed pressure overload-induced overexpression of PIEZO1 (Fig. 4D, E). ALP staining further demonstrated that mechanical unloading delayed PIEZO1-mediated osteogenic degeneration of vertebral growth plate chondrocytes under pressure overload (Fig. 4F). Microgravity‑induced mechanical unloading attenuates vertebral growth plate injury via inhibiting PIEZO1. A Schematic diagram of growth plate chondrocyte treatment: First, chondrocytes were subjected to mechanical loading. Subsequently, the loaded cells were re-seeded into a dedicated culture device, which was then mounted in an RPM (Random Positioning Machine) to simulate microgravity for mechanical unloading, followed by relevant detections. B, C Fluorescent Western blot bands and quantitative analysis of PIEZO1 and ossification-related proteins in the control group (100 kPa), RPM treatment group, GsMTx4 treatment group, and GsMTx4 + RPM combined treatment group after 100 kPa pressure loading. GAPDH was used as a loading control for Western blot analysis. D, E Immunofluorescence analysis of growth plate chondrocytes with mechanical loading alone versus mechanical loading followed by mechanical unloading. F ALP staining analysis in the control group (100 kPa), RPM treatment group, GsMTx4 treatment group, and GsMTx4 + RPM combined treatment group after 100 kPa pressure loading. G. Schematic diagram of the animal treatment protocol: First, mouse caudal vertebrae were subjected to 2 weeks of mechanical loading, followed by 2 weeks of mechanical unloading on the pre-loaded caudal vertebrae. H Observation of mouse caudal vertebrae after compression followed by unloading using Safranin O-fast green staining. I End plate cartilage degeneration score based on intervertebral disc degeneration score. J–L Measurements of the total ossified area, ossification rate, and hypertrophic zone height of the growth plate cartilage. All data are presented as the mean ± SD, with n ≥ 3. Significance was indicated as follows: ns (no significance), **P < 0.01, ***P < 0.001. This in vitro conclusion was further validated in animal models: we applied continuous pressure loading to the caudal vertebrae of mice using a mouse tail elastic compression device for 2 weeks; subsequently, some of the pressure-treated mice were randomly selected, the compression device was removed, and tail suspension was performed for 2 weeks to achieve mechanical unloading, with a total treatment cycle of 1 month (Fig. 4G). Histological examination revealed that: compared with the control group, the ossification process of the caudal vertebral growth plate cartilage in the continuous tail compression group was significantly accelerated, characterized by an earlier appearance of growth plate ossification centers; in contrast, this accelerated ossification was significantly reversed in mice that underwent mechanical unloading after compression, specifically manifested by a reduction in the number of growth plate ossification centers. Meanwhile, in the nucleus pulposus and annulus fibrosus tissues, damage caused by compressive stress and the mitigative effect of mechanical unloading on such damage were also observed (Fig. 4H). The cartilage endplates were scored, and it was found that the endplate cartilage exhibited a higher degeneration score after compression treatment. The endplate degeneration score in the compression followed by mechanical unloading group was lower than that in the compression-only group. Measurements of the total ossified area, ossification rate, and hypertrophic zone height of the growth plate cartilage also revealed that compression treatment resulted in a significantly higher total ossified area and ossification rate, as well as a lower hypertrophic zone height, compared with the control group. Moreover, mechanical unloading after compression could ameliorate these changes (Fig. 4I–L). These results indicate that mechanical unloading can effectively reverse the PIEZO1 upregulation induced by pressure overload and the subsequent acceleration of growth plate cartilage ossification. Discussion In this study, we repositioned “mechanical unloading under microgravity”—a phenomenon previously primarily regarded as detrimental to the musculoskeletal system (e.g., astronaut bone loss)—and developed it into a non-invasive therapeutic strategy to delay the progression of Adolescent Idiopathic Scoliosis (AIS). By integrating clinical observations, in vivo mouse models, and in vitro mechanobiological experiments, we confirmed that mechanical unloading can reverse pressure-induced degeneration and ossification of vertebral growth plate chondrocytes by inhibiting the mechanosensitive ion channel PIEZO1, thereby alleviating AIS-related spinal deformities. In the field of bone-related research, since the normal physiological activities of bone and cartilage depend on mechanical load regulation, mechanical unloading caused by microgravity has long been studied as a damaging factor—such as microgravity-induced bone loss and bone homeostasis imbalance18,19. In cartilage-related studies, various lines of evidence also support that the microgravity environment exerts adverse effects on cartilage function and metabolism20. However, these studies used healthy individuals or untreated cells/animals as controls and did not specifically explore the role of the microgravity environment in “mechanical overload-related diseases” (e.g., AIS). It has been clearly established in existing studies that biomechanical factors are important regulatory factors in the progression of Adolescent Idiopathic Scoliosis (AIS). Scholars such as Stokes used caudal vertebral external fixators to apply compressive stress loading and tensile stress loading to SD rats, respectively, to explore the effect of mechanical stress on vertebral growth. The experimental results showed that the vertebral growth rate of rats in the compressive stress loading group was only 68% of that in the control group, while the vertebral growth rate in the tensile stress loading group reached 114% of that in the control group. This result indicates that mechanical stress can directly regulate vertebral growth and is fully consistent with the Hueter-Volkmann law—which states that compressive stress inhibits spinal growth while tensile stress accelerates it21,22. Based on the above experimental conclusions, clinical practice, and research accumulations, Roaf et al. further proposed the “vicious cycle” mechanism of AIS progression1,2: After the formation of asymmetric scoliosis, the concave side of the scoliosis is continuously subjected to excessive compressive stress, while the stress load on the convex side is significantly reduced. This difference in stress distribution leads to inhibited growth of the concave-side vertebrae and relatively accelerated growth of the convex side, thereby exacerbating the spinal scoliosis deformity. The aggravation of the deformity further increases the compressive stress load on the concave side, eventually forming a vicious cycle of “scoliosis deformity onset—stress imbalance—aggravated scoliosis deformity—further stress imbalance”. The present study was conducted on the basis of this classic theory. In the clinical case, anti-gravity skull traction achieved a significant reduction in the Cobb angle of the patient with severe adolescent idiopathic scoliosis (AIS) via mechanical unloading (F = G1−G2), with the angle decreasing from 79.52° to 37.78°. In animal experiments, early mechanical unloading reduced the scoliosis progression rate by approximately 50% compared with the control group. Our previous clinical studies have also verified the beneficial effect of traction in the treatment of severe spinal scoliosis23. These findings suggested that mechanical unloading can effectively break the vicious cycle of “scoliosis deformity—stress imbalance—aggravated deformity”, thereby providing a novel strategy for the clinical management of AIS. Existing studies have shown that enhanced PIEZO1 expression may promote chondrocyte damage and matrix degradation, induce cartilage degeneration, and drive the progression of osteoarthritis24,25. Our previous studies also found that PIEZO1 overexpression on the concave side of the AIS vertebral growth plate drives chondrocyte apoptosis and ferroptosis, thereby accelerating spinal deformity3,4. This study further expands this mechanistic framework and indicates that mechanical unloading under simulated microgravity can directly reverse the abnormal regulation of PIEZO1: In vitro experiments showed that 100 kPa cyclic pressure stress upregulates PIEZO1 expression in primary growth plate chondrocytes in a time-dependent manner, while simulating microgravity using an RPM downregulates PIEZO1 expression—this result indicates that PIEZO1 is sensitive to both mechanical overload and unloading. In vivo validation experiments further support this conclusion: Mouse tail compression (simulating AIS-related pressure stress) increases PIEZO1 expression in the caudal vertebral growth plate, while mouse tail suspension (simulating microgravity-induced mechanical unloading) decreases PIEZO1 expression. Critically, unloading can reverse the pathological changes caused by mechanical overload: After 2 weeks of tail compression, subsequent 2 weeks of suspension reduced the number of prematurely appearing ossification centers in the growth plate and alleviated damage to the nucleus pulposus and annulus fibrosus. Functional experiments using the PIEZO1 agonist Yoda1 showed that PIEZO1 activation promotes chondrocyte ossification (manifested by enhanced ALP and ARS staining, and upregulated expression of osteogenic markers COL1A2 and RUNX2) while reducing cartilage matrix integrity (manifested by weakened ABS staining and downregulated expression of the cartilage marker COL2A1). In contrast, mechanical unloading blocks pressure-induced PIEZO1 upregulation and subsequent ossification, confirming that PIEZO1 inhibition is the core mechanism by which unloading exerts its therapeutic effect. Clinical observations and previous mouse model data highlight the key clinical application value of mechanical unloading in AIS treatment: A clinical case of a patient with severe AIS showed that after 3 weeks of treatment with skull traction (a well-established anti-gravity unloading technique), the patient’s scoliosis angle was significantly reduced. Experiments using the bipedal standing scoliosis mouse model further confirmed that initiating mechanical unloading (10 h of daily suspension) immediately after scoliosis onset can delay spinal deformity progression within 1 month. This suggests that timely mechanical unloading may serve as an early intervention to slow AIS progression, thereby reducing the need for invasive interventions (such as surgery or local drug delivery) in high-risk pediatric patients. Notably, mechanical unloading provides a non-invasive alternative to the PIEZO1 inhibitor (GsMTx4) delivery strategy we previously reported—the latter requires local implantation via biomaterials, which is an invasive procedure for pediatric patients3. In contrast, unloading-related protocols can be implemented without causing tissue damage. Furthermore, recent studies have demonstrated that specific angular adjustment using custom-designed hospital beds may simulate a mechanical unloading environment26. This finding may address the key challenges of poor compliance and low safety in the treatment of pediatric AIS. Despite these advances, this study has several limitations that require focused attention in future research and clinical translation: Although the bipedal standing mouse model used in this study can simulate AIS-like spinal deformities, it cannot fully recapitulate the complex etiopathogenesis of human AIS (which involves multiple factors such as genetics, hormones, and development). The present study employs tail suspension as a model for altered caudal vertebral mechanical loading, which involves certain biomechanical simplifications and assumptions that have not been directly empirically verified. Although tail suspension is a well-established model for hindlimb unloading, its application to caudal vertebrae does not abolish static compressive forces mediated by intervertebral ligaments. As mice are quadrupedal and have relatively low body mass, static compressive stress on caudal vertebrae is only minimally reduced. Therefore, the term “unloading” refers specifically to the attenuation of physiological dynamic loading, which serves as a critical regulator of caudal vertebral homeostasis, rather than complete unloading of compressive forces. These biomechanical characteristics should be considered when interpreting the present findings. Furthermore, the mouse tail compression and suspension models focus on the caudal vertebrae, whereas human AIS primarily affects the thoracolumbar spine, and its progression is closely associated with the axial biomechanical factors of vertebral bodies. The thoracic spine serves as the weight-bearing central axis of the body, sustaining high-magnitude axial compressive stress, shear stress, and complex mechanical perturbations; it exhibits high expression of PIEZO1 and other mechanosensitive pathways, with efficient and tight mechano-molecular signal transduction that directly participates in vertebral rotation and scoliosis progression. In contrast, the caudal vertebrae are non-weight-bearing structures, only subjected to low-intensity tensile and shear stress generated by tail movement; they have low expression and activation levels of mechanosensitive pathways, with relaxed mechanical sensitivity and polarity regulation, and thus cannot generally simulate the pathological amplification effect driven by abnormal axial mechanics. Although the application of tail compression devices can mitigate this limitation to a certain extent, future studies are still required to verify the effect of mechanical unloading in spine-specific AIS models that better recapitulate human pathological characteristics. In in vitro experiments, the RPM used to simulate microgravity creates a “gravity vector randomization” environment, which differs from the near-complete weightlessness of the real microgravity environment in space. Although the RPM is a well-established ground-based microgravity research tool, the differences in cellular biological responses (e.g., PIEZO1 regulatory kinetics) between RPM-simulated microgravity and real microgravity remain unclear. Future validation is needed in space-derived models or equipment. The clinical protocol for mechanical unloading requires further standardization: In the clinical case of this study, the specific traction force and duration of skull traction were not quantified in detail, and the previous mouse suspension model used a fixed daily treatment duration. To achieve clinical translation, it is necessary to optimize key parameters such as traction force and daily unloading duration based on the severity of AIS and patient age, as well as develop new non-invasive and more tolerable mechanical unloading devices. In summary, this study indicates that mechanical unloading under simulated microgravity can delay AIS progression by targeting PIEZO1—a key mediator of pressure-induced growth plate degeneration. By repositioning the biomechanical effect of microgravity from a “pathological factor” to a “therapeutic tool,” we provide a non-invasive, translatable strategy for AIS treatment—this strategy can be used both for pre-surgical deformity correction and early progression delay. Although further optimization of the treatment protocol and verification of clinical efficacy are needed, this study builds an interdisciplinary bridge between aerospace medicine and clinical orthopedic treatment, opening new avenues for safer and more effective AIS therapy. Methods Reagents Yoda1 (HY-18723) was purchased from Med Chem Express (MCE, USA). Clinical study Clinical trial number: not applicable. In accordance with the Declaration of Helsinki. The clinical research component was approved by the Ethics Review Committee of Shandong Hospital Affiliated to Shandong First Medical University (SWYX: NO.2024-481). To demonstrate the impact of mechanical unloading on scoliosis, this paper presents imaging data from the clinical treatment course of a patient with idiopathic scoliosis, with consent obtained from the patient themselves and their guardian. Anti-gravity skull traction for scoliosis has been widely used in clinical practice. The specific operational standards are as follows: the initial traction weight is 3 kg, which is increased appropriately according to the patient’s tolerance, by 1–2 kg daily until the traction weight reaches 30–50% of the patient’s body weight. For some patients with better tolerance, the traction weight can be appropriately increased (maximum not exceeding 70% of the patient’s body weight). The daily traction duration should reach 10 h, and traction is stopped during sleep27–29. Ethical approval and animal experimental protocols In accordance with the Declaration of Helsinki. All animal procedures were approved by the Animal Care Committee of Shandong Provincial Hospital Affiliated to Shandong First Medical University (NO. NSFC2024-0002) and the Qingdao University Laboratory Animal Management and Ethics Committee (NO. 202310C5708202502123). C57BL/6 J mice were used throughout the study. All invasive procedures were performed under isoflurane inhalation anesthesia. Mice were placed in a sealed anesthesia induction chamber and anesthetized with a mixed gas of 2–5% isoflurane and oxygen; after the animals lost their righting reflex and showed diminished corneal reflex, they were removed from the induction chamber, and 1–2% isoflurane was continuously administered via a face mask to maintain the anesthetic state. After all invasive procedures were completed, isoflurane delivery was stopped, and the mice were transferred to a well-ventilated and temperature-appropriate recovery area, where their recovery of spontaneous respiration, righting reflex and limb motor function was continuously monitored; the mice were only returned to regular housing cages after they fully regained spontaneous movement and consciousness, with stable vital signs. Before tissue harvest, mice were euthanized by excessive isoflurane inhalation; mice were placed in a sealed anesthesia induction chamber, and anesthesia was induced with a mixture of 2–5% isoflurane and oxygen, after the animals lost their righting reflex and showed diminished corneal reflex, the isoflurane concentration in the chamber was maintained or increased to 3–5% to achieve excessive administration, and the mixed gas was continuously supplied until the mice completely stopped breathing and heartbeat, vital signs were closely observed during the whole process, and administration was continued for an additional 5–10 min after respiration ceased. Scoliosis traction-suspension experiment Thirty 3-week-old specific pathogen-free (SPF) female mice were used in this experiment. After 1 week of acclimatization feeding (until 4 weeks of age), all mice underwent bilateral forelimb amputation combined with tail resection (Fig. 1C) to establish a bipedal upright mouse model. The mice were allowed 1 week of postoperative recovery to ensure physical adaptation after surgery. Subsequently, the height of food and water devices was adjusted to guide the mice to maintain a continuous upright stance, facilitating scoliosis induction. Four weeks after the model induction surgery, scoliosis was confirmed in all mice via X-ray imaging examination. The formal experiment was then initiated: these 30 mice were randomly divided into two groups, with 15 mice receiving 10 h of daily suspension treatment to achieve spinal stress unloading (traction-suspension group), and the remaining 15 mice served as the control group with routine feeding and no suspension intervention. Tail compression and subsequent mechanical unloading experiment This experiment included three models: the tail compression-only model, the tail suspension mechanical unloading-only model, and the tail compression followed by mechanical unloading model. A total of 20 8-week-old specific pathogen-free (SPF) female mice were selected and divided into four groups (5 mice per group): the control group, the compression‑only group, the mechanical unloading‑only group, and the compression followed by unloading group. The tail compression method was modified from the protocol described by Xia et al.30. After successful anesthesia, mice were fixed in the prone position on an operating table with their limbs immobilized. The surgical area was depilated and disinfected, followed by the implantation of a static pressure circular external fixator on the vertebral bodies. The fixator was equipped with four compression springs, each exerting a pressure of 10 kPa. During the procedure, Kirschner wires were fixed on the mouse caudal vertebrae starting from the second vertebra proximal to the tail base, with one vertebra skipped between each wire, ensuring that 2 intervertebral spaces were loaded. Two crossed Kirschner wires on the same vertebra were placed vertically and fixed to the circular external fixator to maintain balance. Care was taken to apply uniform pressure to avoid skin ulceration, infection, or necrosis in the surgical area. Finally, the nuts on the external fixator were rotated to compress the springs, which were fixed after adjustment to the preset shortening length to achieve continuous static pressure loading. The tail suspension mechanical unloading method was modified from the protocol described by Li et al.31. In this study, mechanical unloading is explicitly defined as the attenuation of physiological dynamic mechanical loading (including weight bearing, tail bending, torsion, and cyclic loading during movement) rather than the complete elimination of static compressive forces between caudal vertebrae. The distal end of the mouse tail was suspended with sterile silk thread, leaving the hind limbs suspended and the forelimbs naturally touching the ground; suspension was maintained for 10 h daily. Mice in the control group received routine feeding without suspension treatment. For the tail compression followed by unloading group, mice first underwent 2 weeks of continuous tail compression using the aforementioned “tail compression model” method. Subsequently, the circular external fixator was removed, and the mice were subjected to 2 weeks of tail suspension mechanical unloading using the aforementioned “tail suspension mechanical unloading” method. DR analysis After the establishment of the bipedal upright mice model, from the second week, following intraperitoneal injection anesthesia, the mice were fixed on a special film board for X-ray photography, and the incisors were suspended on the thin wire, and the whole plate showed a 30° angle. Cell isolation and culture The cartilage endplate was isolated from the endplate of 5-day-old C57BL/6J male mice. After dissection, the cartilage endplate was digested with 0.25% trypsin for 20 min and 0.25% collagenase solution for 6 h. Primary chondrocytes were collected and passaged at 80% confluence in DMEM/F12 medium (L370KJ, Basalmedia, Shanghai Basalmedia Technologies Co., Ltd., China) containing 10%FBS (LONSERA, Suzhou Shuangru BiologyScience & Technology Co., Ltd., China) or 10%FBS (BIOFIL, Guangzhou JetBio-Filtration Co., Ltd). Chondrocytes used in this study were 1st or 2nd-generation (P1 or P2) chondrocytes, which were isolated from vertebral growth plate cartilage and subcultured for 1 or 2 passages. Culture bottle and other materials were purchased from Guangzhou JetBio-Filtration Co., Ltd. Cell stress loading Pressure loading uses a self-developed compressive stress loading device with independent intellectual property rights (CN202221667470.X) to carry out stress loading on cells according to demand. Cells were seeded in 25-mm cell culture flasks. Following administration of designated pharmacological agents or reagents, the flasks were placed within the compression chamber of a custom-built device. The sealed chamber-maintained gas composition and temperature identical to the cell culture incubator to ensure cellular viability. As static mechanical stress has been documented to induce apoptosis and alter structural characteristics, extracellular matrix composition, and gene expression32, initial experiments quantified PIEZO1 expression across five mechanical loading gradients (0, 10, 40, 70, and 100 kPa) applied for 6 h. Subsequent experiments employed a loading intensity of 100 kPa based on these preliminary findings. Microgravity simulation A desktop Random Positioning Machine (RPM) (DYNAFLOW, Beijing, China) was used to simulate microgravity conditions. Growth plate cells were inoculated into culture vessels, with air bubbles avoided and liquid flow minimized. The culture vessels were fixed on the RPM, which was then placed in an incubator at 37 °C with 5% CO₂. Western blot analysis Chondrocytes were seeded into six-well plates at a density of 5 × 105 cells/well and cultured until 80% confluent. After treatment, total protein was extracted. Cells were washed with PBS three times and lysed with 100 μl RIPA lysis buffer (Boster, China, AR0102) supplemented with 1% proteinase inhibitor cocktail for 30 min on ice. The lysates were collected and centrifuged at 13,000 rpm for 20 min, the supernatants were collected, and total protein concentration was measured using a BCA assay kit (Boster, China, AR0146). Next, 25 μg of protein from each sample was separated by electrophoresis using a 10% SDS-PAGE gel(Cat No. PG212; Epizyme, Shanghai, China), before being transferred to a PVDF membrane (Millipore, United States). Membranes were then blocked with 5% BSA at room temperature for 1 h and incubated with primary antibodies anti-PIEZO1(15939-1-AP, Proteintech, 1:2000), anti-COL2A1 (28459-1-AP, Cohesion, 1:2000), anti-RUNX2 (20700-1-AP, Proteintech, 1:2000), anti-COL1A2(P103304, Epizyme, 1:2000) and GAPDH (60004-1-Ig, Proteintech,1:2000). Blots were incubated with primary antibody overnight at 4 °C. After washing with TBST three times, membranes were incubated with corresponding secondary antibodies (LF102, Epizyme, 1:5000) or incubate the membrane with fluorescein conjugated secondary antibody in 10 ml of secondary antibody dilution buffer at room temperature for 1 h at room temperature. Bands were detected using a Western ECL Substrate Kit (Thermo Pierce, USA) and analyzed with the Bio-Rad scanner’s built-in software (Bio-Rad, Hercules, CA) or using the Odyssey CLx Infrared Fluorescence Scanning Imaging System. Band density was quantified using ImageJ. Immunohistochemistry (IHC) After tissue slices were deparaffinized, and antigen retrieval was performed, the specimens were subsequently incubated overnight with rabbit polyclonal antibodies against anti-PIEZO1(15939-1-AP, Proteintech, 1:200). After a thorough wash, each section was incubated with biotinylated goat anti-rabbit secondary antibody (Boster, 1:500) at room temperature for 15 min. The sections were finally colored with DAB and counterstained with hematoxylin. Images of the stained slices were analyzed using the software Image-Pro Plus. To quantify immuno-positive cells, at least five random fields of the cartilage were selected and the ratio of immune positive cells to total cells was calculated for each field. Immunofluorescence staining (IF) Cells were seeded into 24-well plates at a density of 1 × 105 cells/ml. After treatment, cells were fixed with 4% paraformaldehyde for 15 min and permeabilized using 0.5% Triton X-100 incubated for 20 min at room temperature. After blocking with 5% BSA for 1 h at room temperature, cells were then incubated with anti-PIEZO1(15939-1-AP, Proteintech, 1:200) overnight at 4 °C. After primary antibody incubation, cells were next incubated with Cy3-conjugated goat anti-rabbit secondary antibody in the dark for 1 h. After washing with PBS three times and incubation with DAPI for 10 min, images were taken using a fluorescence microscope (Evos Fl auto, Life Technologies, USA). Safranine O staining Safranine O staining was conducted to assess alterations in proteoglycans, utilizing a Safranine O staining kit (G1371, SolarBio, China), in accordance with the manufacturer’s prescribed protocol. Quantitative analysis of cartilage endplate degeneration Quantitative analysis was performed on Safranin O staining of the endplates based on the novel histological intervertebral disc degeneration scoring system proposed by Melgoza et al.17. A 3‑grade scoring system with scores ranging from 0 to 2 for each item and no difference in weight was adopted, which was derived from the independent assessment of three core pathological features of the endplate: cell distribution, fissures/microfractures, and Schmorl’s nodes. Specifically, the endplate cell distribution was scored as 0 (cells with laminar arrangement), 1 (dispersed cells without empty lacunae), or 2 (lacunar cavitation with no viable cells); fissures/microfractures were scored as 0 (no defect), 1 (a small number of non‑penetrating interlamellar fissures), or 2 (severe full‑thickness penetrating fissures/microfractures); Schmorl’s nodes were scored as 0 (absent) or 2 (present with nucleus pulposus infiltration into the vertebral growth plate, with no grade 1 manifestation). The total CEP score ranged from 0 to 6 (0 = no degeneration, 6 = severe degeneration) and was calculated by the direct summation of the scores of the three features. Analysis of total ossified area and ossification rate of vertebral growth plates Quantitative analysis of the ossified area was performed using ImageJ software based on scanned images of Safranin O staining. First, a microscope standard scale bar with the same magnification was imported. The conversion between pixels and actual length (μm) was completed via the “Analyze→Set Scale” function, and “Global” was checked to apply the setting to all images. Subsequently, the region of interest (ROI) of the cartilage endplate was manually outlined, strictly excluding vertebral cancellous bone, annulus fibrosus/nucleus pulposus of the intervertebral disc, as well as damaged or folded areas of the sections. The staining threshold was set using the “Image→Adjust→Threshold” function to specifically select the fast green–stained ossified areas (safranin O–stained normal cartilage tissue was excluded). The actual area of the ossified region (μm²) for a single section was obtained via the “Analyze→Measure” function. The total ossified area of the cartilage endplate (S_total) was calculated by summing the ossified areas of all valid sections containing intact cartilage endplates. The overall area of the cartilage endplate in each section was measured simultaneously and summed. The ossification rate (%) was calculated as (total ossified area/total area of the cartilage endplate) × 100%. All measurements were performed by the same observer, and 10% of the samples were selected for double-blind repeat verification to ensure measurement consistency. Measurement of hypertrophic zone height in vertebral growth plates Morphometric analysis was performed using ImageJ software based on scanned images of Safranin O staining. First, pixel-to-actual length calibration was completed using a microscope scale bar. Six measurement points were selected at equal intervals along the straight segment of the hypertrophic zone in the growth plate. The linear distance from the upper border of the hypertrophic zone (the junction between the proliferative zone and the hypertrophic zone) to the lower border (the junction between the hypertrophic zone and calcified cartilage) was measured perpendicular to the long axis of the growth plate. The mean value of these measurements was calculated as the average height of the hypertrophic zone for that section, and the results were expressed in μm. Evaluation of chondrocyte ossification and degeneration Ossification was evaluated using a combination of alkaline phosphatase (ALP) and alizarin red S (ARS) staining. ALP staining indicates early osteogenic differentiation activity, whereas ARS staining labels late-stage mineralized matrix nodules. The two methods can mutually validate each other and enable a more comprehensive assessment of ossification. Cartilage degeneration was assessed by alcian blue (ABS) staining alone. As a classic and specific method for detecting cartilage proteoglycans—whose loss constitutes the core feature of cartilage degeneration—ABS staining allows direct visualization of proteoglycan content and provides a direct and reliable reflection of the degree of cartilage degeneration. Alizarin red staining The mineralization of endplate chondrocytes was analyzed by alizarin red staining33. The chondrocytes of the vertebral growth plate were seeded in a 24-well plate at a density of 1 × 105 cells / ml and cultured to 80% fusion. Next, the osteogenic induction medium (Cyagen Biosciences, Guangzhou, China) was used instead of the medium, and the cells were cultured for another 21 days. Rinse with distilled water and fix it with paraformaldehyde at room temperature for 20 min. According to the instructions provided by the manufacturer, alizarin red (G1452, solarbio, China) was used to dye at room temperature for 15 min. Alkaline phosphatase staining ALP staining was used to evaluate the degree of chondrocyte mineralization34. In our study, the activity of ALP was the highest after 7 days of osteogenic culture induction. Therefore, the chondrocytes of vertebral growth plate were inoculated into 24-well plate at the density of 1 × 105 cells per well. Once they reached 80% confluence, osteogenic differentiation medium (Cyagen Biosciences, China) was applied for 7 days. On the 7th day, according to the instructions provided by the manufacturer, the cells were stained using the ALP kit (P0321S, Beyotime, China). Alcian blue staining Alcian Blue staining (ABS) was used to evaluate chondrogenesis26. Vertebral growth plate chondrocytes were seeded into 12-well plates at a density of 1 × 10⁵ cells per well. Once they reached 80% confluence, different concentrations of Yoda1 were administered for 7 consecutive days. The cells were rinsed with PBS and fixed with formaldehyde at room temperature for 30 min. Subsequently, staining was performed with Alcian Blue (A5268-10G, Sigma, Germany) at room temperature according to the manufacturer’s provided instructions. Statistical analysis All data are presented as the mean ± SD of at least three independent experiments. Data were pre-processed by normalizing to control conditions. First, the Shapiro–Wilk test, which is appropriate for small sample sizes, was used to formally assess the normality of all data. The test results confirmed that the data in this study conformed to a normal distribution. Differences among three or more group means were analyzed using one-way ANOVA followed by Dunnett’s post hoc tests. The independent-sample t-test was used to assess the difference between the two group means. All statistical analyses were performed using GraphPad Prism 10.0 (GraphPad Software, USA). A two-tailed p < 0.05 was considered statistically significant for all tests, with significance levels denoted as *p < 0.05, **p < 0.01, ***p < 0.001, and p ≥ 0.05 indicated as not significant (ns). Materials availability The datasets generated and/or analyzed during the current study are not publicly available because the clinical data involve patient privacy, and other data are related to ongoing research that has not yet been published, but are available from the corresponding author upon reasonable request. Supplementary information the full uncropped Gels and Blots image(s) Acknowledgements Fei Chen, Shuqing Chen and Xingzhi Jing contributed equally to this work. The authors sincerely acknowledge the entire staff of the Department of Spine Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University and Department of Spinal Surgery, The Affiliated Hospital of Qingdao University, who offered assistance throughout the course of this study. The present study was supported by Taishan Scholars Program of Shandong Province (No. tstp20250511) and Scientific Research Projects of Shandong Medical Association (YXH2024YS019) and Space Science and Application Project of China Space Station Application and Development Program (KJZ-YY-NSM0619). Author contributions F.-C. contributed to the research design, analysis of the data, and manuscript writing. F.S.-P. and Z.C.-C. contributed to the acquisition and analysis of the data and wrote the program. S.Q.-C., Y.Y.-F. and H.-Z. contributed to the acquisition and analysis of the data. J.Y.-L. and G.H.-G. contributed to the acquisition and analysis of the data. Y.M.-X., T.-L., J.-D., and X.Z.-J. initiated and designed the study. All authors were fully involved in the study and approved the final version of this manuscript. Data availability The datasets generated and/or analyzed during the current study are not publicly available because the clinical data involve patient privacy, and other data are related to ongoing research that has not yet been published, but are available from the corresponding author upon reasonable request. Competing interests The authors declare no competing interests. Consent for publication The corresponding author has received consent for publication. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. These authors contributed equally: Fei Chen, Shuqing Chen, Xingzhi Jing. Contributor Information Jun Dong, Email: tungjun@163.com. Tao Li, Email: litao19812022@163.com. Yongming Xi, Email: xym700118@163.com. Supplementary information The online version contains supplementary material available at 10.1038/s41526-026-00604-1. References Associated Data Supplementary Materials the full uncropped Gels and Blots image(s) Data Availability Statement The datasets generated and/or analyzed during the current study are not publicly available because the clinical data involve patient privacy, and other data are related to ongoing research that has not yet been published, but are available from the corresponding author upon reasonable request.